BioCorRx (BICX) Liabilities and Shareholders Equity (2010 - 2026)

BioCorRx (BICX) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $2.3 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 65.82% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (up 124.47% YoY) and the FY2025 annual result came in at $2.1 million, up 456.36% from the prior year.
• Liabilities and Shareholders Equity climbed to $2.3 million in Q1 2026 per BICX's latest filing, from $2.1 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $7.5 million in Q3 2025, with the low at $317444.0 in Q1 2024.
• Average Liabilities and Shareholders Equity over 5 years is $2.0 million, with a median of $766594.0 recorded in 2022.
• Year-over-year, Liabilities and Shareholders Equity soared 2042.45% in 2025 and sank 65.82% in 2026.
• BioCorRx's Liabilities and Shareholders Equity stood at $766594.0 in 2022, then slumped by 49.27% to $388887.0 in 2023, then slipped by 0.76% to $385941.0 in 2024, then jumped by 456.36% to $2.1 million in 2025, then gained by 8.27% to $2.3 million in 2026.
• Business Quant data shows BICX's Liabilities and Shareholders Equity at $2.3 million in Q1 2026, $2.1 million in Q4 2025, and $7.5 million in Q3 2025.